Unlike full-length growth hormone, AOD-9604 does not upregulate IGF-1, does not induce insulin resistance in reported toxicology models, and does not measurably affect linear growth in adult animal models
Additionally, some individuals may experience side effects such as nausea or diarrhea
For midlife women, who may already be managing multiple chronic conditions or navigating metabolic changes tied to menopause, the buzz around GLP-1s may raise questions: Could these drugs help with overlapping health challenges
Let's explore B12 micronutrient injections in detail, covering topics - safe administration, optimal MIC-B12 dosage, and factors influencing dosage
It is not approved by Health Canada for human therapeutic, diagnostic, or weight loss use